mRNA |
lapatinib |
GDSC1000 |
pan-cancer |
AAC |
0.17 |
0.0002 |
mRNA |
thapsigargin |
GDSC1000 |
pan-cancer |
AAC |
0.11 |
0.001 |
mRNA |
KIN001-055 |
GDSC1000 |
pan-cancer |
AAC |
0.1 |
0.002 |
mRNA |
UNC0638:navitoclax (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.002 |
mRNA |
BRD-K71935468 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.003 |
mRNA |
EKB-569 |
GDSC1000 |
pan-cancer |
AAC |
0.093 |
0.003 |
mRNA |
navitoclax:PLX-4032 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.1 |
0.004 |
mRNA |
Crizotinib |
gCSI |
pan-cancer |
AAC |
0.15 |
0.006 |
mRNA |
BRD-K94991378 |
CTRPv2 |
pan-cancer |
AAC |
-0.11 |
0.006 |
mRNA |
thapsigargin |
gCSI |
pan-cancer |
AAC |
0.14 |
0.009 |